|     home    |     search     |     content     |     mail     |     login     |
included studies of GGD (395)

241891501-3-2014Is serosorting effective in reducing the risk of HIV infection among men who have sex with men with casual sex partners?
239081241-1-2014The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.
243399135-12-2013HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
232036951-12-2013Cohort profile: the International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study.
2392161728-11-2013Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM.
2422526114-11-2013High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011.
2311798031-10-2013Risk of tuberculosis following HIV seroconversion in high-income countries.
240984541-10-2013The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.
240971971-10-2013Seroepidemiology of high-risk HPV in HIV-negative and HIV-infected MSM: the H2M study.
2391297924-9-2013Natural history of HIV-control since seroconversion.
2405968223-9-2013HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.
240404049-9-2013[new study]
2398507828-8-2013Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.
238840571-8-2013Hepatitis C virus reinfection following treatment among people who use drugs.
238840631-8-2013Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.
2393548925-7-2013Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.
235258381-7-2013Undetectable viral load and the decision to engage in unprotected anal intercourse among HIV-positive MSM.
235324791-7-2013Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
236978131-6-2013Ongoing risk behavior and the presence of HCV-RNA affect the hepatitis C virus (HCV)-Specific CD4(+) T cell response.
233471241-6-2013Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
240245251-4-2013High awareness of hepatitis C virus (HCV) but limited knowledge of HCV complications among HIV-positive and HIV-negative men who have sex with men.
232665601-4-2013[new study]
2352710718-3-2013[new study]
232259001-3-2013Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
232235941-3-2013Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
231482891-2-2013Low bone mineral density, regardless of HIV status, in men who have sex with men.
233727531-1-2013Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.
219109301-9-2012Estimating the force of infection for HCV in injecting drug users using interval-censored data.
219199871-3-2012The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
2215697120-2-2012Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era.
221099441-1-2012Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.
2186034528-11-2011Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.
2211066915-11-2011Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.
219205741-11-2011Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages.
219491651-9-2011Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.
216998031-9-2011No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion.
216810581-9-2011Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
217345641-9-2011Macrophages and HIV-1.
2186163323-8-2011Serosorting and sexual risk behaviour according to different casual partnership types among MSM: the study of one-night stands and sex buddies.
218502705-8-2011Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase.
216536641-8-2011Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.
2157230717-7-2011Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
218115741-7-2011Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.
217506741-7-2011CD39/adenosine pathway is involved in AIDS progression.
214900921-7-2011Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.
215931471-7-2011Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.
215619181-7-2011Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
213682919-6-2011HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes.
217314961-6-2011Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.
215929921-6-2011Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS.

displaying records 1 to 50 of 395


This form lists all, or all included studies of an institute.
  • click on a studycode to view the details of a study
  • if 'all studies' are displayed, clicking on 'included studies' will display those
  • if 'included studies' are displayed, clicking on 'all studies' will display those
  • by default the first 50 records are displayed, clicking on 'display all' will do just that